NCT07442929

Brief Summary

Different mixtures of local anesthetics or local anesthetics with adjuvants that are known to precipitate in vitro are tested in human cerebrospinal fluid (CSF). CSF is gained from patients with normal pressure hydrocephalus scheduled for elective lumbar puncture. Patients signed an ICF for leftover samples. CSF will be assessed for pH values at different timepoints (t0-t3; 0 to 60 minutes). In a second step six commonly used mixtures of LA with LA or LAs with adjuvants will be mixed using the following mixture ratios: ropivacaine 0.75% + lidocaine 2% (ratio 1:1), ropivacaine 0,75% + mepivacaine 2% (ratio 1:1), ropivacaine 0.75% + chloroprocaine 2% (ratio 1:1), lidocaine 2% + sodium bicarbonate 8.4% (ratio 1:0.1), ropivacaine 0.75% + lidocaine 2% + sodium bicarbonate 8.4% (ratio 1:1:0.1) and ropivacaine 0.75% + dexamethasone (1.5:1). The used mixture ratios are inspired by commonly mixtures described in the current literature and have been proven to precipitate in vitro. For every mixture, a Grade of Crystallisation will be determined at baseline without CSF and then at t0 (immediately) to t3 (60 minutes) every 15 minutes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
2mo left

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Sep 2025Sep 2026

Study Start

First participant enrolled

September 1, 2025

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

September 18, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

March 2, 2026

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 18, 2025

Last Update Submit

February 26, 2026

Conditions

Keywords

local anesthetics;local anesthetic mixturescerebrospinal fluidin vitrocrystallizationpHadjuvants

Outcome Measures

Primary Outcomes (1)

  • Grade of Crystallisation

    For the grading of detectable precipitations, a scale from 0 (no signs of precipitation / single particulates \< 10 μm) to 5 (heavy polymorphic crystallization: \> 100 solid bodies \> 10 μm, and \> 1 solid body \> 50 μm or \> 1 solid body \> 100 μm) will be used.

    1 hour

Secondary Outcomes (2)

  • pH value and of CSF and CSF LA mixtures

    1 hour

  • pCO2 of CSF and CSF LA mixtures

    1 hour

Study Arms (1)

Patients with normal pressure hydrocephalus scheduled for elective lumbar puncture

Patients with normal pressure hydrocephalus scheduled for elective lumbar puncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with normal pressure hydrocephalus scheduled for elective lumbar puncture.

You may qualify if:

  • Patients with normal pressure hydrocephalus scheduled for elective lumbar puncture.

You may not qualify if:

  • Age \< 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Innsbruck

Innsbruck, Tyrol, 6020, Austria

RECRUITING

Related Publications (1)

  • Hoerner E, Stundner O, Putz G, Steinfeldt T, Mathis S, Gasteiger L. Crystallization of ropivacaine and bupivacaine when mixed with different adjuvants: a semiquantitative light microscopy analysis. Reg Anesth Pain Med. 2022 Jun 23:rapm-2022-103610. doi: 10.1136/rapm-2022-103610. Online ahead of print.

    PMID: 35738668BACKGROUND

MeSH Terms

Conditions

Hydrocephalus

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Elisabeth Gasteiger, MD PhD

    Medical Unicersity Innsbruck

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2025

First Posted

March 2, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

March 2, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Data will only be shared on a reasonable request.

Shared Documents
ANALYTIC CODE
Time Frame
Data will only be shared on a reasonable request.
Access Criteria
Data will only be shared on a reasonable request.

Locations